Interestingly, EIF4A3 levels were significantly higher in TCGA patients with mutations in key HCC genes, such as TP53, CTNNB1, RB1, AXIN2, CCNE1 or CCND1 (Figure 2F). Here, CTNNB1 is linked to hepatocellular carcinoma.